Report Categories
View AllRecent Articles
View All
FGSN F and G Annuities and Life Inc posts 266 percent Q4 2025 EPS miss shares dip 033 percent today
How Ideal Power IPWR earnings power stacks up historically Q4 2025 Profit Surprises
DNOW Inc DNOW posts 188 percent Q4 2025 revenue growth shares tick higher despite slight EPS miss
IZM ICZOOM shares slide as Q3 revenue tumbles 17 percent amid challenging market conditions
IBR vs REPAYE Choosing the Right Federal Student Loan Repayment Plan
Singapore Shares Edge Higher Amid Cautious MidEast Sentiment STI Adds 04
Penta Capital Pauses Sumer Sale Amid Accounting Sector Valuation Pressure
European Companies Pursue Reindustrialisation Amid Declining Investment Plans and AIs Growing Economic Role
Trump Seeks Supreme Court Intervention to Postpone TikTok Ban Market Watches Closely
April Jobs Report Expected to Show Modest 55000 Payroll Gain Amid Cooling Labor Market
Thomson Reuters TRI Q1 2026 Earnings EPS Beats Estimates on Operational Strength
CTEV Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges
i3 Verticals Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gains
KSCP Q1 2026 Earnings Wider Loss Weighs on Sentiment as Stock Climbs
ASR Q1 2026 Earnings EPS Misses Estimates Shares Dip 225
cbdMD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions
Talen Energy TLN Slips 24 as Traders Weigh Key Support and Resistance Levels
GigCapital9 Corp Units GIXXU Holds Steady at 1018 Amid Low Volatility
Hilton Grand Vacations HGV Hovering Near Support as Resistance Caps Upside
Baxter International BAX Edges Higher as Stock Holds Above Key Support Levels
NOVONIX NVX Stages a Sharp Recovery Testing Key Resistance Levels
How SmithMidland Corporation SMID pricing offsets input costs
Is Nathans Famous NATH stock a good investment this year 068 20260420
VOYA Voya Financial rises 13 percent after Q4 2025 results despite EPS miss and modest year over year revenue growth
Is PMV Pharmaceuticals PMVP stock priced below intrinsic value Institutional Demand 20260422
IRIX IRIDEX Corporation beats Q4 2025 EPS estimates posts 82 percent revenue gain yet shares fall 187 percent
External Links
Jim Cramer Recommends Two Stocks Sees Nearly 20 Upside in One
CNTY Q1 2026 Earnings EPS Beats Estimates Despite Continued Loss
Solventum SOLV Holds Steady Near Support as Traders Eye Resistance at 8067
Average HELOC Rate Holds at 721 Truist Tops Yahoo Finances Best Lender List
Gold and Silver Prices Decline as Precious Metals Face Continued Pressure
Novartis Raises FullYear Sales and Profit Guidance Amid Strong Drug Performance
Morgan Stanley Maintains Bullish Stance on NextEra Energy Despite Price Target Adjustment
Security Incident Near White House Raises Security Concerns May Influence Market Sentiment
UK Exports to US Drop 25 as Trump Tariffs Reshape Trade Balance
Trump Signals No Rush on Iran Nuclear Deal Naval Blockade to Continue